vs

Side-by-side financial comparison of AVITA Medical, Inc. (RCEL) and SuperCom Ltd (SPCB). Click either name above to swap in a different company.

AVITA Medical, Inc. is the larger business by last-quarter revenue ($17.6M vs $14.2M, roughly 1.2× SuperCom Ltd). SuperCom Ltd runs the higher net margin — 37.5% vs -66.0%, a 103.5% gap on every dollar of revenue. On growth, SuperCom Ltd posted the faster year-over-year revenue change (-1.5% vs -4.3%). SuperCom Ltd produced more free cash flow last quarter ($-3.6M vs $-6.1M).

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

Super.com is a technology company headquartered in San Francisco and co-founded by Hussein Fazal and Henry Shi. The company provides financial services, including reward programs and travel bookings.

RCEL vs SPCB — Head-to-Head

Bigger by revenue
RCEL
RCEL
1.2× larger
RCEL
$17.6M
$14.2M
SPCB
Growing faster (revenue YoY)
SPCB
SPCB
+2.8% gap
SPCB
-1.5%
-4.3%
RCEL
Higher net margin
SPCB
SPCB
103.5% more per $
SPCB
37.5%
-66.0%
RCEL
More free cash flow
SPCB
SPCB
$2.5M more FCF
SPCB
$-3.6M
$-6.1M
RCEL

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
RCEL
RCEL
SPCB
SPCB
Revenue
$17.6M
$14.2M
Net Profit
$-11.6M
$5.3M
Gross Margin
81.2%
61.2%
Operating Margin
-59.1%
16.3%
Net Margin
-66.0%
37.5%
Revenue YoY
-4.3%
-1.5%
Net Profit YoY
-0.3%
79.5%
EPS (diluted)
$-0.37
$1.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RCEL
RCEL
SPCB
SPCB
Q4 25
$17.6M
Q3 25
$17.1M
Q2 25
$18.4M
$14.2M
Q1 25
$18.5M
Q4 24
$18.4M
Q3 24
$19.5M
Q2 24
$15.2M
$14.4M
Q1 24
$11.1M
Net Profit
RCEL
RCEL
SPCB
SPCB
Q4 25
$-11.6M
Q3 25
$-13.2M
Q2 25
$-9.9M
$5.3M
Q1 25
$-13.9M
Q4 24
$-11.6M
Q3 24
$-16.2M
Q2 24
$-15.4M
$3.0M
Q1 24
$-18.7M
Gross Margin
RCEL
RCEL
SPCB
SPCB
Q4 25
81.2%
Q3 25
81.3%
Q2 25
81.2%
61.2%
Q1 25
84.7%
Q4 24
87.6%
Q3 24
83.7%
Q2 24
86.1%
52.3%
Q1 24
86.4%
Operating Margin
RCEL
RCEL
SPCB
SPCB
Q4 25
-59.1%
Q3 25
-53.6%
Q2 25
-60.5%
16.3%
Q1 25
-63.9%
Q4 24
-54.1%
Q3 24
-70.6%
Q2 24
-102.8%
7.7%
Q1 24
-155.0%
Net Margin
RCEL
RCEL
SPCB
SPCB
Q4 25
-66.0%
Q3 25
-77.3%
Q2 25
-53.9%
37.5%
Q1 25
-74.9%
Q4 24
-63.0%
Q3 24
-82.9%
Q2 24
-101.3%
20.6%
Q1 24
-168.0%
EPS (diluted)
RCEL
RCEL
SPCB
SPCB
Q4 25
$-0.37
Q3 25
$-0.46
Q2 25
$-0.38
$1.32
Q1 25
$-0.53
Q4 24
$-0.44
Q3 24
$-0.62
Q2 24
$-0.60
$1.19
Q1 24
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RCEL
RCEL
SPCB
SPCB
Cash + ST InvestmentsLiquidity on hand
$18.2M
$15.0M
Total DebtLower is stronger
$23.6M
Stockholders' EquityBook value
$-16.6M
$37.3M
Total Assets
$56.4M
$65.5M
Debt / EquityLower = less leverage
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RCEL
RCEL
SPCB
SPCB
Q4 25
$18.2M
Q3 25
$23.3M
Q2 25
$15.7M
$15.0M
Q1 25
$25.8M
Q4 24
$35.9M
Q3 24
$44.4M
Q2 24
$54.1M
$5.7M
Q1 24
$68.2M
Total Debt
RCEL
RCEL
SPCB
SPCB
Q4 25
Q3 25
Q2 25
$23.6M
Q1 25
Q4 24
Q3 24
Q2 24
$29.2M
Q1 24
Stockholders' Equity
RCEL
RCEL
SPCB
SPCB
Q4 25
$-16.6M
Q3 25
$-6.7M
Q2 25
$-12.9M
$37.3M
Q1 25
$-4.6M
Q4 24
$4.5M
Q3 24
$12.2M
Q2 24
$23.9M
$13.8M
Q1 24
$32.6M
Total Assets
RCEL
RCEL
SPCB
SPCB
Q4 25
$56.4M
Q3 25
$63.7M
Q2 25
$58.1M
$65.5M
Q1 25
$69.6M
Q4 24
$79.7M
Q3 24
$81.1M
Q2 24
$87.8M
$49.6M
Q1 24
$97.4M
Debt / Equity
RCEL
RCEL
SPCB
SPCB
Q4 25
Q3 25
Q2 25
0.63×
Q1 25
Q4 24
Q3 24
Q2 24
2.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RCEL
RCEL
SPCB
SPCB
Operating Cash FlowLast quarter
$-5.4M
$-2.2M
Free Cash FlowOCF − Capex
$-6.1M
$-3.6M
FCF MarginFCF / Revenue
-34.7%
-25.3%
Capex IntensityCapex / Revenue
3.8%
10.0%
Cash ConversionOCF / Net Profit
-0.41×
TTM Free Cash FlowTrailing 4 quarters
$-33.5M
$-14.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RCEL
RCEL
SPCB
SPCB
Q4 25
$-5.4M
Q3 25
$-5.2M
Q2 25
$-10.2M
$-2.2M
Q1 25
$-10.3M
Q4 24
$-8.1M
Q3 24
$-7.2M
Q2 24
$-12.8M
$-950.0K
Q1 24
$-20.9M
Free Cash Flow
RCEL
RCEL
SPCB
SPCB
Q4 25
$-6.1M
Q3 25
$-6.2M
Q2 25
$-10.8M
$-3.6M
Q1 25
$-10.5M
Q4 24
$-9.7M
Q3 24
$-11.0M
Q2 24
$-15.4M
$-1.6M
Q1 24
$-22.0M
FCF Margin
RCEL
RCEL
SPCB
SPCB
Q4 25
-34.7%
Q3 25
-36.1%
Q2 25
-58.4%
-25.3%
Q1 25
-56.9%
Q4 24
-52.7%
Q3 24
-56.1%
Q2 24
-101.6%
-10.8%
Q1 24
-198.2%
Capex Intensity
RCEL
RCEL
SPCB
SPCB
Q4 25
3.8%
Q3 25
5.5%
Q2 25
2.8%
10.0%
Q1 25
1.2%
Q4 24
8.8%
Q3 24
19.2%
Q2 24
17.5%
4.2%
Q1 24
10.3%
Cash Conversion
RCEL
RCEL
SPCB
SPCB
Q4 25
Q3 25
Q2 25
-0.41×
Q1 25
Q4 24
Q3 24
Q2 24
-0.32×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons